RecruitingNCT05745805

Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Enrollment

600 participants

Start Date

Jan 12, 2023

Study Type

OBSERVATIONAL

Conditions

COVID-19 Post-COVID-19 Syndrome Post-Acute COVID-19 Acute COVID-19

Summary

Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Simultaneous cortico-spinal magnetic resonance imaging, Serum for people with acute covid-19, covid-19, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.